Table 3. CTC count normalized to 7.5 ml blood in patients in all 3 groups.
| Pt Identifier | CTC Count |
|---|---|
| Neoadjuvant (baseline/followup):* | |
| Neo1 | 50/60 |
| Neo2 | 10/Not applicable |
| Neo3 | 60/7 |
| Neo4 | 8/2 |
| Neo5 | 0/4 |
| Neo6 | 0/2 |
| Neo7 | 11/750 |
| Neo8 | 2/0 |
| Neo9 | 19/6 |
| Neo10 | 1/3 |
| Neo11 | 179/0 |
| Neo12 | 128/0 |
| Neo13 | 88/3 |
| Neo14 | 1/0 |
| Neo15 | 3/34 |
| Neo16 | 15/9 |
| Neo17 | 358/33 |
| Neo18 | 183/100 |
| Neo19 | 233/Not applicable |
| Neo20 | 8/14 |
| Metastatic: | |
| Met1 | 32 |
| Met2 | 26 |
| Met3 | 146 |
| Met4 | 88 |
| Met5 | 26 |
| Met6 | 1 |
| Met7 | 33 |
| Met8 | 0 |
| Met9 | 154 |
| Met10 | 34 |
| Met11 | 6 |
| Control: | |
| HD1 | 1 |
| HD2 | 0 |
| HD3 | 2 |
| HD4 | 0 |
| HD5 | 3 |
| HD6 | 4 |
| HD7 | 4 |
| HD8 | 8 |
| HD9 | 2 |
| HD10 | 1 |
| HD11 | 2 |
| HD12 | 0 |
| HD13 | 0 |
*
CTC averaged in subset with multiple tubes tested at same time point.